Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
213.5 USD | -2.35% | -0.73% | +3.74% |
Apr. 15 | Morgan Stanley Adjusts Primerica's Price Target to $250 From $245, Keeps Equalweight Rating | MT |
Mar. 19 | Primerica Insider Sold Shares Worth $365,115, According to a Recent SEC Filing | MT |
Strengths
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.74% | 7.41B | B | ||
+3.05% | 95.15B | B | ||
+6.72% | 94.71B | B- | ||
-14.11% | 77.24B | B+ | ||
+18.68% | 74.93B | D+ | ||
+6.69% | 30.04B | B | ||
+18.06% | 27.87B | B | ||
+4.32% | 26.97B | A | ||
-1.21% | 16.99B | C+ | ||
-9.10% | 15.16B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PRI Stock
- Ratings Primerica, Inc.